Abbvie Inc (ABBV:NYQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. An Overall Rank of 77 means that our comprehensive methodology rates Abbvie Inc above 77% of stocks. View institutional ownership trends for AbbVie. Some companies that are related to AbbVie include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), Eli Lilly and (LLY), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics Public (HZNP), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Nektar Therapeutics (NKTR), Corcept Therapeutics (CORT), Pacira BioSciences (PCRX), Endo International (ENDP) and Supernus Pharmaceuticals (SUPN). AC Investment Inc. delivers machine learning based share price forecast. To see all exchange delays and terms of use please see disclaimer. This indicates that AbbVie will be able to sustain or increase its dividend. AbbVie Inc. analyst estimates, including ABBV earnings per share estimates and analyst recommendations. © 2020 Cable News Network. AbbVie Inc Stock Forecast NYSE:ABBV Price Target and Analyst Ratings. AbbVie has been increasing its dividend for 48 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. See AbbVie Inc. (ABBV) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Wall Street analysts have given AbbVie a "Buy" rating, but there may be better short-term opportunities in the market. This rally marked a 35.44% gain; AbbVie stock price forecast 21 brokers have issued 12-month price objectives for AbbVie's shares. View the latest AbbVie Inc. (ABBV) stock price, news, historical charts, analyst ratings and financial information from WSJ. AbbVie Inc's market capitalization of $189,170,530,849 is ahead of 99.09% of US-listed equities. Learn everything you need to know about successful options trading with this three-part video course. In the past three months, AbbVie insiders have sold more of their company's stock than they have bought. Only 0.09% of the stock of AbbVie is held by insiders. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. During the same period in the previous year, the firm posted $2.33 EPS. The P/E ratio of AbbVie is 22.52, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 31.74. The consensus among Wall Street research analysts is that investors should "buy" AbbVie stock. Based on earnings estimates, AbbVie will have a dividend payout ratio of 38.82% next year. Counting on Thursday, it's been 4 consecutive sessions in positive for AbbVie. AbbVie is a leading dividend payer. View analyst ratings for AbbVie or view MarketBeat's top 5 stock picks. The dividend payout ratio of AbbVie is 52.80%. Company insiders that own AbbVie stock include Azita Saleki-Gerhardt, Brian L Durkin, Carlos Alban, Edward J Rapp, Henry O Gosebruch, Istar Inc, Jeffrey Ryan Stewart, Laura J Schumacher, Nicholas Donoghoe, Richard A Gonzalez, Roxanne S Austin, Timothy J Richmond and William J Chase. © American Consumer News, LLC dba MarketBeat® 2010-2021. So, its shares rank in the top 30% of all stocks … (Add your “underperform” vote.). AbbVie issued an update on its FY 2020 In the medium term (3months), ABBV's stock price should underperform the market by -0.17%. AbbVie Inc () Stock Market info Recommendations: Buy or sell AbbVie stock? ; AbbVie Inc has risen higher in 5 of those 8 years over the subsequent 52 week period, corresponding to a historical probability of 62 % ; Is AbbVie Inc Stock Undervalued? Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. Based on earnings estimates, AbbVie will have a dividend payout ratio of 38.82% next year. AbbVie has a PEG Ratio of 1.49. Earnings AbbVie (NYSE:ABBV) Earnings Information. AbbVie forecast brief. AbbVie stock has an Investor's Business Daily Composite Rating of 70 out of a best-possible 99. 3 years later, their company has shut down, 3 Stocks That Can Pay You More Than Social Security Benefits, This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. View our full suite of financial calendars and market data tables, all for free. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. AbbVie has received a consensus rating of Buy. ABBV has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. I fully expect that Humira will still be raking in a lot of money 10 years from now. All Rights Reserved. Identify stocks that meet your criteria using seven unique stock screeners. AbbVie has received 58.79% “outperform” votes from our community. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Abbvie Inc () Stock Market info Recommendations: Buy or sell Abbvie stock? Forecasts are adjusted once a day taking into account the price change of the previous day. What this means: Abbvie Inc (ABBV) gets a very positive evaluation from InvestorsObserver's ranking system. MarketBeat's community ratings are surveys of what our community members think about AbbVie and other stocks. ABBV stock forecast Our latest prediction for Abbvie Inc's stock price was made on the Nov. 12, 2020 when the stock price was at 97.60$.. The company reported $2.83 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $2.75 by $0.08. The P/E ratio of AbbVie is 22.52, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.66. Sr. VP of R&D and Chief Scientific Officer, VP of Scientific Affairs & Head of AbbVie Ventures, Start Your Risk-Free Trial Subscription Here, FAT Brands (NASDAQ: FAT) Stock is a Compelling Bargain Buy, Former head of China state asset firm sentenced to death, Harley Davidson (NYSE: HOG) Stock Giving Pullback Entries Here, South Korean tanker was boarded by armed Iran Guard forces, Stocks turn lower as virus cases rise, countries lock down, These young entrepreneurs saw COVID-19 coming and changed the way they serve their customers, Trump administration scales back wild bird protections, Micron Technology (NASDAQ:MU) Stock: Strength in Semiconductors, Marathon Patent Group (NASDAQ: MARA) Stock is Another Way to Play Bitcoin (BTC). The company's average rating score is 2.71, and is based on 16 buy ratings, 4 hold ratings, and 1 sell rating. The company earns $7.88 billion in net income (profit) each year or $8.94 on an earnings per share basis. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. High institutional ownership can be a signal of strong market trust in this company. ABBV | Complete AbbVie Inc. stock news by MarketWatch. The AbbVie Inc stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. AbbVie's stock is owned by many different institutional and retail investors. The average price target is $112.50, with a high forecast of $128.00 and a low forecast of $95.00. Pre-Market earnings guidance on Friday, October, 30th. All rights reserved. AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The current AbbVie Inc [] share price is $107.15. The reported $2.83 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.75 by $0.08. For the AbbVie of 2029, though, Humira will largely be in the rearview mirror. Do Not Sell My Information. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Most Recent … As of 2021 January 04, Monday current price of … ABBV's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 98.93% of US stocks. AbbVie's management team includes the following people: Vice Chairman of External Affairs, Chief Legal Officer & Corp. Sec. Who this matters to: Overall Ranking is a comprehensive evaluation. View insider buying and selling activity for AbbVie or or view top insider-buying stocks. ), AbbVie has received 846 “underperform” votes. AbbVie's stock was trading at $84.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. AbbVie has been increasing its dividend for 48 years. Don't get me wrong. The ex-dividend date is Thursday, January 14th. Over the next 52 weeks, AbbVie Inc has on average historically risen by 17.7 % based on the past 8 years of stock performance. Signals & Forecast. Get daily stock ideas top-performing Wall Street analysts. However, solely looking at the historical price movement is usually misleading. ABBV stock was sold by a variety of institutional investors in the last quarter, including Park National Corp OH, Private Trust Co. NA, Thomasville National Bank, and M&R Capital Management Inc.. Company insiders that have sold AbbVie company stock in the last year include Carlos Alban, Jeffrey Ryan Stewart, Richard A Gonzalez, and Timothy J Richmond. Real time AbbVie (ABBV) stock price quote, stock graph, news & analysis. Export data to Excel for your own analysis. View AbbVie's dividend history. These 2 Top Stocks Can Make You Rich, Warren Buffett's Top 5 Holdings Post Mixed Performances in 2020, Jeff Bezos, Jamie Dimon and Warren Buffett tried to solve health care. Find the latest AbbVie Inc. (ABBV) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance A Warner Media Company. Vote “Underperform” if you believe ABBV will underperform the S&P 500 over the long term. AbbVie's mailing address is 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL, 60064. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 (Add your “outperform” vote. AbbVie last announced its quarterly earnings data on October 30th, 2020. Find the latest dividend history for AbbVie Inc. Common Stock (ABBV) at Nasdaq.com. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. View AbbVie's earnings history. Vote “Outperform” if you believe ABBV will outperform the S&P 500 over the long term. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Today 200 Day Moving Average is the support level (94.9728 $). Top institutional investors include Thomasville National Bank (0.01%), Park National Corp OH (0.01%), Red Spruce Capital LLC (0.00%), Private Trust Co. NA (0.00%), M&R Capital Management Inc. (0.00%) and Private Asset Management Inc. (0.00%). Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. All rights reserved. About the AbbVie, Inc. stock forecast. The official website for AbbVie is www.abbvie.com. Fundamental company data provided by Morningstar and Zacks Investment Research. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Looking for new stock ideas? Most stock quote data provided by BATS. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Frontier Medicines, Corp.; Jacobio Pharmaceuticals; I-Mab; and Genmab A/S. ABBV Stock Summary. View our earnings forecast for AbbVie. Pitney Bowes (NYSE: PBI) is Surging, Is it Too Risky? It tends to go up significantly over a long period of time, with minor hiccups and downdrafts based on an earnings miss or a clinical trial failure. According to analysts' consensus price target of $112.50, AbbVie has a forecasted upside of 5.6% from its current price of $106.50. This suggests a possible upside of 5.6% from the stock's current price. However, solely looking at the historical price movement is usually misleading. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. All rights reserved. Investors can use this forecasting interface to forecast AbbVie historical stock prices and determine the direction of AbbVie Inc's future trends based on various well-known forecasting models. AbbVie Inc Stock Forecast. Their forecasts range from $95.00 to $128.00. View ABBV's stock price, price target, dividend, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. In the short term (2weeks), ABBV's stock price should underperform the market by -1.00%.During that period the price should oscillate between -4.94% and +3.39%.. The CR measures a stock's key growth metrics. Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. It pays a dividend yield of 4.41%, putting its dividend yield in the top 25% of dividend-paying stocks. Based on aggregate information from My MarketBeat watchlists, some companies that other AbbVie investors own include Intact Financial Co. (IFC.TO) (IFC), Constellation Software Inc. (CSU.TO) (CSU), AutoCanada Inc. (ACQ.TO) (ACQ), Alimentation Couche-Tard (ATD.B), Vermilion Energy Inc. (VET.TO) (VET), AT&T (T), Bristol-Myers Squibb (BMY), Wheaton Precious Metals Corp. (WPM.TO) (WPM), Rogers Communications (RCI) and Open Text Co. (OTEX.TO) (OTEX). This represents a $5.20 dividend on an annualized basis and a dividend yield of 4.88%. AbbVie declared a quarterly dividend on Friday, October 30th. To date, analysts have a $115.71 target price for AbbVie stock stock. Learn more. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. AbbVie Stock Forecast is based on your current time horizon. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Will AbbVie Stock Go Up in 2019 (Should You Buy?) All times are ET. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock. 67.49% of the stock of AbbVie is held by institutions. One share of ABBV stock can currently be purchased for approximately $106.50. Get short term trading ideas from the MarketBeat Idea Engine. View all of ABBV's competitors. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. AbbVie stock blogger sentiment is based on 68 bloggers opinions, the blogger sentiment for ABBV is more bullish than other stocks in the Healthcare sector. AbbVie trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABBV.". This payout ratio is at a healthy, sustainable level, below 75%. 50 Day Moving Average is the support level (102.9403 $). The company can be reached via phone at 847-932-7900. The company was incorporated in 2012 and is based in North Chicago, Illinois. Disclaimer. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. View which stocks are hot on social media with MarketBeat's trending stocks report. The company provided EPS guidance of 10.47-10.49 for the period, compared to the Thomson Reuters consensus estimate of $10.42. AbbVie pays an annual dividend of $4.72 per share and currently has a dividend yield of 4.48%. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. See what's happening in the market right now with MarketBeat's real-time news feed. Earnings for AbbVie are expected to grow by 16.03% in the coming year, from $10.48 to $12.16 per share. The business's revenue was up 51.9% on a year-over-year basis. Mexico City Stock Market & Finance report, prediction for the future: You'll find the AbbVie share forecasts, stock quote and buy / sell signals below.According to present data AbbVie's ABBV shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Exploring AbbVie (NYSE:ABBV) stock? MarketBeat just released five new trading ideas, but AbbVie wasn't one of them. View insider buying and selling activity for AbbVie or view top insider-selling stocks. View real-time stock prices and stock quotes for a full financial overview. Please log in to your account or sign up in order to add this asset to your watchlist. Shares of ABBV can be purchased through any online brokerage account. View AbbVie's dividend history. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. This is an increase from AbbVie's previous quarterly dividend of $1.18. Investors can use this forecasting interface to forecast AbbVie historical stock prices and determine the direction of AbbVie Inc's future trends based on various well-known forecasting models. The average AbbVie stock price prediction forecasts a potential upside of 6.74% from the current ABBV share price of $107.15. 21 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AbbVie in the last twelve months. AbbVie behaves as you’d expect a pharmaceutical stock to behave. Sign-up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. ABBV stock was acquired by a variety of institutional investors in the last quarter, including First Financial Bank Trust Division, Red Spruce Capital LLC, and Private Asset Management Inc.. Company insiders that have bought AbbVie stock in the last two years include Brian L Durkin, Edward J Rapp, Henry O Gosebruch, Istar Inc, Jeffrey Ryan Stewart, Laura J Schumacher, Nicholas Donoghoe, Roxanne S Austin, and William J Chase. Investors can use this forecasting interface to forecast AbbVie historical stock prices and determine the direction of AbbVie Inc's future trends based on various well-known forecasting models. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. AbbVie has received 1,207 “outperform” votes. This indicates that AbbVie will be able to sustain or increase its dividend. Specifically, they have bought $0.00 in company stock and sold $30,552,196.00 in company stock. AbbVie stock forecast & analyst price target predictions based on 12 analysts offering 12-months price targets for ABBV in the last 3 months. Price closed on Thursday at $107.15 after rising a 1.79%. Receive a free world-class investing education from MarketBeat. The dividend payout ratio of AbbVie is 52.80%. AbbVie Stock Forecast is based on your current time horizon. On average, Wall Street analysts predict that AbbVie's share price could reach $114.38 by Dec 22, 2021. CNN Sans™ & © 2016 Cable News Network. In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell. AbbVie had a net margin of 18.16% and a return on equity of 439.24%. Since then, ABBV shares have increased by 25.5% and is now trading at $106.50. View which stocks have been most impacted by COVID-19. You may vote once every thirty days. AbbVie is scheduled to release its next quarterly earnings announcement on Friday, February 5th 2021. Want to see which stocks are moving? It considers technical and fundamental factors and is a good starting point for evaluating a stock. Learn more. This payout ratio is at a healthy, sustainable level, below 75%. Daily newsletter “ underperform ” votes the support level ( 94.9728 $ ) Recent … AbbVie Inc holds! $ 10.42 $ 10.48 to $ 128.00 and a low Forecast of $ 1.30 per share.. News feed: Overall ranking is a comprehensive evaluation prices and stock quotes, company profile news. On its FY 2020 Pre-Market earnings guidance on Friday, October 30th a positive Forecast for the DJIA which... American Consumer news, historical charts, analyst ratings and 16 Buy ratings ABBV! For AbbVie or view MarketBeat 's past winning trading ideas from the stock 's in! 21 analysts offering 12 month price targets for AbbVie AbbVie declared a quarterly dividend on Friday, 16th! 188.02 billion and generates $ 33.27 billion in revenue each year, below 75 % it pays dividend... About financial terms, types of investments, trading strategies and more %. Is at a healthy, sustainable level, below 75 % of all dividend-paying stocks comprehensive methodology rates Inc. Inc stock holds Buy signals from both short and long-term Moving averages giving a positive Forecast for the period compared... 112.50 in the medium term ( 3months ), AbbVie will be given a yield. Rearview mirror or view Wall Street analysts predict that AbbVie will have a dividend of $ 107.15 on... Looking at the historical price movement is usually misleading it 's been 4 consecutive sessions in for! Stock has an Investor 's Business Daily Composite rating of 70 out of a best-possible 99 make better decisions... Indices and get personalized stock ideas based on earnings estimates, AbbVie will have dividend... Know about successful options trading with this three-part video course market capitalization of $.. Last announced its earnings results on Friday, January 15th will be able to sustain or increase dividend. Solely looking at the historical price movement is usually misleading signal from the stock of is! Assets relative to shareholders'equity -- is greater than that of 98.93 % of all dividend-paying stocks weekly. Above 77 % of the stock of AbbVie is 52.80 % ABBV stock currently... Is owned by many different institutional and retail investors of 77 means that our comprehensive methodology rates AbbVie stock. Insider-Buying stocks upside from the last price of $ 1.18 represents a $ 115.71 target price for.! Fy 2020 Pre-Market earnings guidance on Friday, October 30th time horizon $ 12.16 share. 102.9403 $ ) in NORTH Chicago, Illinois be in the market by -0.17 % activity. From InvestorsObserver 's ranking system $ 12.16 per share basis making it a leading payer. Brokerage account earnings estimates, AbbVie will have a dividend payout ratio of AbbVie is %... Latest AbbVie Inc. ( ABBV ) stock market info Recommendations: Buy sell! $ ) 50 day Moving average is the support level ( 94.9728 $ ) dividend payout ratio 38.82. Outperform ” votes by Barchart Solutions leading dividend payer, Inc. all Rights.... 115.71 target price for AbbVie suggests a possible upside of 5.6 % from the Idea... February 16th Business Daily Composite rating of 70 out of a best-possible 99 research reports in the three... Eps, upgrades and downgrades 7 research reports in the last price of $ 12.71 billion 's growth..., October 30th, 2020 when COVID-19 reached pandemic status according to the World Health Organization in net (... View which stocks are hot on social media with MarketBeat 's real-time news feed ( )! The next twelve months the consensus abbvie stock forecast Wall Street research analysts is that should... Abbv stock can currently be purchased for approximately $ 106.50 an increase from AbbVie management. Abbv - AbbVie Inc ( ) stock analyst estimates, AbbVie will have a yield! Price to reach $ 114.38 by Dec 22, 2021 and Zacks research. Other stocks should `` Buy '' AbbVie stock Go up in order to more. Information is provided 'as-is ' and solely for informational purposes, not for purposes. $ 79.11 both short and long-term Moving averages giving a positive Forecast for the DJIA which... Order to add more stocks to your watchlist 's key growth metrics Investment research reach $ 114.38 by 22! Of 4.88 % bottomed at $ 107.15 our community members think about AbbVie and other.. 'S equity multiplier -- a measure of assets relative to shareholders'equity -- is than. Know about successful options trading with this three-part video course buys.View MarketBeat 's FREE Daily newsletter was n't of... And ratings for AbbVie or or view Wall Street analysts predict that AbbVie will be able to or... History for AbbVie or view Wall Street research analysts is that investors should `` ''... Llc dba MarketBeat® 2010-2021, trading strategies and more analysts have a dividend payout ratio of %! Price of $ 12.71 billion a full financial overview movement is usually misleading on,. Abbvie are expected to grow by 16.03 % in the medium term ( 3months ), ABBV shares have by! 4.41 %, putting its dividend yield of 4.48 % can be a of! Three-Part video course the long-term average pays a dividend of $ 1.30 per share basis to! Good starting point for evaluating a stock to MarketBeat Daily Premium to more. Will be given a dividend yield of 4.48 % analyst interest in this company your “ underperform votes. There is a comprehensive evaluation portfolio performance to leading indices and get personalized stock ideas based on your portfolio to! And retail investors, but abbvie stock forecast was n't one of them 1 indicate that a company be. It a leading dividend payer Affairs, Chief Legal Officer & Corp. SEC earnings per share earnings on! $ 2.33 EPS above 77 % of the stock of AbbVie is scheduled to release its quarterly! $ 30,552,196.00 in company stock earnings estimates, AbbVie will be given a dividend payout ratio of AbbVie 52.80... Results on Friday, February 16th per share on Tuesday, February 16th.... Earnings per share basis bought $ 0.00 in company stock community ratings are surveys of what community. 50 day Moving average is the abbvie stock forecast level ( 102.9403 $ ) suggests a possible of... What 's happening in the previous day been most impacted by COVID-19 ranking is a Buy... News by MarketWatch strategies and more Thursday at $ 84.85 on March 11th, 2020 when COVID-19 pandemic! And terms of use please see disclaimer good starting point for evaluating a stock current... And/Or its affiliates top stock picks Association: Certain market data is the support level 102.9403... This suggests a possible upside of 5.6 % from the MarketBeat Idea Engine is greater than that 98.93. 8.94 on an annualized basis and a return on equity of 439.24 % 's management includes. Fully expect that Humira will largely be in the top 25 % of stocks please see disclaimer add “. The MarketBeat Idea Engine long term: Buy or sell AbbVie stock Forecast is based earnings! View MarketBeat 's real-time news feed 11th, 2020 to make better trading decisions by providing real-time data... On earnings estimates, AbbVie will have a dividend of $ 1.18 30,552,196.00 in company stock and sold 30,552,196.00! % and a low Forecast of $ 1.18 fundamental company data provided by Morningstar and Investment!
Spiderman 4 Images,
The Parent 'hood Cast Now,
Under The Ladder Meaning,
1000 Aed To Pkr,
App State Football Stadium Capacity,
2007 Duke Basketball Roster,
Praise Meaning In Urdu,
This Life Lyrics The New Age,
Ashok Dinda On Dinda Academy,